EBITDA of Wesfarmers Limited Health division 2022-2023

Published by Statista Research Department, Jun 4, 2024

In 2023, the Health division of Wesfarmers Limited recorded their earnings before interest, taxes depreciation, and amortization (EBITDA) as 45 million Australian dollars. The smaller EBITDA recorded in the previous year was due to the aquisition of API on March 31st, 2022.

EBITDA of Wesfarmers Limited Health division from 2022 to 2023 (in million Australian dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

August 2023

Region

Australia, Australia and Oceania

Survey time period

2022 to 2023

Supplementary notes

*Wesfarmers Health division was formed in March 2022, after the acquisition of Australian Pharmacueticals Industry (API). 

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Australia "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Australia

Overview

6

Prescription medication

5

Major Pharmaceuticals

5

Pharmaceutical retailers

7

Trends

6

Further Content: You might find this interesting as well

Topics

Pharmaceutical industry in AustraliaGlobal pharmaceutical industryDrug Store/Pharmacy Market in the U.S.Top pharmaceutical drugsPharmaceutical research and development (R&D)
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.